Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen–induced allergic rhinoconjunctivitis in an environmental exposure unitAnne K. Ellis, Hendrik Nolte, Mark W. Tenn et al.|Annals of Allergy Asthma & Immunology|2018Cited by 29
Proceedings of the Canadian society of allergy and clinical immunology annual scientific meeting 2015Manstein Kan, Sonia Cellot, Henrique Bittencourt et al.|Allergy Asthma and Clinical Immunology|2016Cited by 20
Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen seasonsAnne K. Ellis, Roderick P. Hafner, Charles W. Frankish et al.|Journal of Allergy and Clinical Immunology|2019Cited by 19
Advances in rhinitisAnne K. Ellis, Mark W. Tenn|Annals of Allergy Asthma & Immunology|2017Cited by 15
Onset of action for loratadine tablets for the symptomatic control of seasonal allergic rhinitis in adults challenged with ragweed pollen in the Environmental Exposure Unit: a post hoc analysis of total symptom scoreMark W. Tenn, Anne K. Ellis, Lisa M. Steacy et al.|Allergy Asthma and Clinical Immunology|2018Cited by 15